GlassScriptPhysician profile
Andrew G Chan
NPI 1902285844
$9,436.64
in general payments reported to CMS, 2019-2025
10 companies · $2,436 in 2025
The $2,436 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.83 · 2020: $115 · 2021: $2,400 · 2022: $4,152 · 2024: $295 · 2025: $2,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,692 · Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,692.42 |
| Food and Beverage | $1,037.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $4,225.14 | 2022-2025 | Other - Miscellaneous |
| Titan Surgical Group, LLC | $3,404.39 | 2021-2025 | |
| Arthrex, INC. | $748.40 | 2025 | |
| Globus Medical, INC. | $601.95 | 2022 | |
| Medical Device Business Services, INC. | $147.59 | 2025 | Velys |
| Depuy Synthes Sales INC. | $136.00 | 2022 | |
| Smith+Nephew, INC. | $114.98 | 2020 | |
| Csl Behring | $23.01 | 2019 | |
| Curiteva, INC. | $18.36 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $16.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.